Bain Capital and Norwest Venture led a $130m Series B round in Apreo Health.

Bain Capital, an investment company, and Norwest Venture, a venture capital firm, led a $130m Series B round in Apreo Health, a clinical-stage medical device company, with participation from F-Prime Capital, Lightstone Venture, Santé Venture, and Intuitive Venture. “Apreo is addressing one of the most underserved populations in chronic obstructive pulmonary disease (COPD) and doing so with clinical clarity and executional rigor. This is a step-change in how we approach emphysema care. The solution is both elegant in design and built for broad, scalable delivery. We’re proud to support Apreo in this next chapter,” Zack Scott, Norwest General Partner.